NDC 0270-1315

ISOVUE 300

Iopamidol

ISOVUE 300 is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Bracco Diagnostics Inc. The primary component is Iopamidol.

Product ID0270-1315_01b4c288-3a85-406e-9c0a-bc801f85ed52
NDC0270-1315
Product TypeHuman Prescription Drug
Proprietary NameISOVUE 300
Generic NameIopamidol
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2014-06-20
Marketing CategoryNDA / NDA
Application NumberNDA020327
Labeler NameBracco Diagnostics Inc
Substance NameIOPAMIDOL
Active Ingredient Strength612 mg/mL
Pharm ClassesRadiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0270-1315-45

10 BOTTLE in 1 BOX (0270-1315-45) > 200 mL in 1 BOTTLE
Marketing Start Date2014-06-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0270-1315-50 [00270131550]

ISOVUE 300 INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018735
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1985-12-31

NDC 0270-1315-41 [00270131541]

ISOVUE 300 INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA020327
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1994-10-12

NDC 0270-1315-25 [00270131525]

ISOVUE 300 INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018735
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1985-12-31

NDC 0270-1315-45 [00270131545]

ISOVUE 300 INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA020327
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2014-06-20

NDC 0270-1315-35 [00270131535]

ISOVUE 300 INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018735
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1985-12-31

NDC 0270-1315-47 [00270131547]

ISOVUE 300 INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018735
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1985-12-31

NDC 0270-1315-95 [00270131595]

ISOVUE 300 INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA020327
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2014-06-20

NDC 0270-1315-98 [00270131598]

ISOVUE 300 INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA020327
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1994-10-12

NDC 0270-1315-30 [00270131530]

ISOVUE 300 INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018735
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1985-12-31

Drug Details

Active Ingredients

IngredientStrength
IOPAMIDOL612 mg/mL

OpenFDA Data

SPL SET ID:416ab996-a2e8-4fe1-a9c9-f10b86df3bb5
Manufacturer
UNII

Pharmacological Class

  • Radiographic Contrast Agent [EPC]
  • X-Ray Contrast Activity [MoA]

NDC Crossover Matching brand name "ISOVUE 300" or generic name "Iopamidol"

NDCBrand NameGeneric Name
76381-315ISOVUE 300ISOVUE 300
0270-1314ISOVUEIOPAMIDOL
0270-1315ISOVUEIOPAMIDOL
0270-1316ISOVUEIOPAMIDOL
0270-1317ISOVUEIOPAMIDOL

Trademark Results [ISOVUE]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ISOVUE
ISOVUE
85423219 4243227 Dead/Cancelled
Centrix, Inc.
2011-09-15
ISOVUE
ISOVUE
75239760 2132582 Dead/Cancelled
BRACCO DIAGNOSTICS, INC.
1997-02-07
ISOVUE
ISOVUE
73299442 1237972 Live/Registered
E. R. Squibb & Sons, Inc.
1981-02-25

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.